So sayeth MLBPA’s boss:
Michael Weiner spoke Wednesday after a meeting of the union’s executive board. He said he expected announcements about the drug program “before too long.”
Weiner says the union and MLB have spoken about adding in-season tests for human growth hormone next year. There also is discussion about making the tests more sophisticated for all performance-enhancing drugs.
And no matter how awesome these tests are, the first time someone besides some minor league free agent gets caught, someone will yell about the tests not being good enough. Because, in the bizarro land of baseball writers, effective tests that catch cheaters are evidence that the system is broken. At least, that’s what I’ve gathered.
The Phillies announced on Tuesday that the club traded pitcher Alec Asher to the Orioles for a player to be named later.
Asher, 25, was the victim of a roster crunch. He was not going to make the 25-man roster and the starting rotation at Triple-A Lehigh Valley was already full. The Phillies acquired him from the Rangers in the July 2015 Cole Hamels trade.
Asher had good results in 27 2/3 innings in the big leagues last year, posting a 2.28 ERA with a 13/4 K/BB ratio. While it didn’t show in those stats, the right-hander sometimes struggles with command and he doesn’t miss bats often enough to make up for it. The Orioles, however, are happy to add some pitching depth.
Ervin Santana will once again start on Opening Day for the Twins, MLB.com’s Rhett Bollinger reports. He’ll face the Royals at home in a day game on Monday, April 3.
The last pitcher to start back-to-back Opening Days for the Twins was Carl Pavano in 2011-12.
Santana, 34, is entering the third year of a four-year, $55 million contract signed in December 2014. Last season, the right-hander finished with a solid 3.38 ERA and a 149/53 K/BB ratio over 181 1/3 innings.